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Abstract 
Background 
Fibromyalgia (FM) is a chronic pain syndrome with a high prevalence of alexithymia, a personality 
disposition that affects emotional self-awareness. The present study aimed to investigate the 
relationship between alexithymia and pain, differentiating between the sensory and affective 
components of pain experience, in a sample of FM patients. 
Methods 
One hundred and fifty-nine FM patients completed a battery of tests assessing pain experience, pain 
intensity, alexithymia and psychological distress. In order to characterize the clinical profile of 
alexithymic FM patients, alexithymic and non-alexithymic groups were compared on the different 
measures. Two regression analyses were performed on the total sample, in order to investigate the 
relationship between alexithymia and pain, controlling for psychological distress.  
Results 
Alexithymic FM patients presented higher scores on all the clinical measures compared to non-
alexithymic ones. Positive correlations were found between alexithymia and the affective, but not 
the sensory, dimension of pain experience variables. Regression analyses showed that alexithymia 
(difficulty identifying feelings factor) ceased to uniquely predict affective pain, after controlling for 
psychological distress, particularly anxiety. In addition, none of the alexithymia variables 
significantly explained pain intensity variance. Finally, a significant effect of anxiety in mediating 
the relationship between alexithymia and affective pain was found. 
Limitations 
No longitudinal data were included.  
Conclusions 
These findings show the presence of higher levels of pain and psychological distress in alexithymic 
vs. non-alexithymic FM patients, and a relevant association between alexithymia and the affective 
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dimension of pain experience. Specifically, this relationship appears to be significantly mediated by 
anxiety.  
 
Abbreviations 
FM, Fibromyalgia; FIOU, Fibromyalgia Integrated Outpatient Unit; QUID, Questionario 
Italiano sul Dolore; FIQ, Fibromyalgia Impact Questionnaire; TAS-20, Toronto Alexithymia 
Scale; DIF, Difficulty Identifying Feelings; DDF: Difficulty Describing Feelings; EOT, 
Externally-Oriented Thinking; HADS, Hospital Anxiety and Depression Scale; DT, Distress 
Thermometer; VIF, Variance Inflation Factor 
Keywords: Fibromyalgia; Alexithymia; Pain; Anxiety; Depression; Emotional distress. 
 
Introduction  
Fibromyalgia (FM) is a syndrome primarily characterized by chronic, widespread musculoskeletal 
pain (Mease et al., 2005; Mease et al., 2009). Its prevalence is estimated to be 3–6% of the world 
population (WHO, 2008) and it occurs predominantly in women (Anderberg et al., 2000; Branco et 
al., 2010). The etiology of this syndrome is not completely understood, but growing evidence 
suggests that FM could be considered a central sensitization syndrome, caused by increased 
sensitivity of the central nervous system to pain signals (Williams and Gracely, 2006).  
Although pain represents the core feature of FM, the symptomatology often includes a 
heterogeneous series of other conditions, such as physical and mental fatigue, disrupted or  
non-restorative sleep, headache, irritable bowel, psychiatric disorders, cognitive impairment, and 
other functional complaints (Abeles et al., 2007; Mease et al., 2005; Schmidt-Wilcke and Clauw, 2011).  
Among the psychological factors, a high prevalence of depression (20–80%) and anxiety disorders  
(13–64%) has been widely reported (Fietta et al., 2007; Montoya et al., 2005). Only recently have 
researchers started to focus their attention also on alexithymia, a personality trait, largely observed 
in “psychosomatic” disorders (Taylor, 2000). Alexithymia is characterized by difficulty in 
identifying and describing subjective feelings, difficulty in distinguishing between feelings and 
bodily sensations of emotional arousal, restricted imagination processes, and a stimulus-bound, 
externally oriented cognitive style (Sifneos, 1972; Taylor et al., 1997). Most of the studies have 
reported high levels of alexithymia in FM patients, suggesting the presence of a deficit in emotional 
self-awareness (Castelli et al., 2012; Di Tella et al., 2015; Sayar et al., 2004; Steinweg et al., 2011).  
The inability to adequately identify one’s own feelings could interfere with the successful 
regulation of emotions, resulting in increased negative affects and chronic sympathetic hyperarousal 
(Lumley et al., 1996). Moreover, the failure to correctly recognize physical sensations as the bodily 
expressions of emotions could lead alexithymic individuals to misinterpret their emotional arousal 
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as signs of disease, further worsening the whole symptomatology (Lumley et al., 1996; Tuzer et al., 
2011).  
Previous studies have, in fact, shown a strong positive association between alexithymia scores and 
scores for negative affectivity, especially anxiety and depression (Honkalamp et al., 2000; Luminet 
et al., 2001; Malt et al., 2002), suggesting a possible role of alexithymia in intensifying 
psychological distress.  
Alexithymia has also been found to be positively associated with pain intensity and pain-related 
functioning in different chronic pain conditions (Glaros and Lumley, 2005; Lumley et al., 2002). 
However, the results are still controversial and in some cases non-significant associations (Cox et 
al., 1994; Friedberg and Quick, 2007; Millard and Kinsler, 1992) or mixed results have been 
yielded (Celikel and Saatcioglu, 2006; Lumley et al., 2005). This pattern of outcomes has also been 
shown in FM syndrome; no correlation or positive association was found between alexithymia and 
different pain measures (Huber et al., 2009; Malt et al., 2002; Martínez et al., 2015; Sayar et al., 2004).  
One possible explanation for these unclear results is the multidimensional characterization of pain. 
Pain, indeed, is not a unique entity, but includes at least two components, one sensory and the other 
affective (Lumley et al., 2002; Melzack and Katz, 1999). The sensory dimension refers more to the 
intensity of pain perception, while the affective one can be considered the unpleasant feelings 
experienced as a consequence of chronic pain. Discriminating between these two components is 
important because they are influenced by different mechanisms and based on specialized brain 
systems (Melzack and Casey, 1968; Melzack and Wall, 1988). The sensory-discriminative 
dimension of pain is influenced primarily by the rapidly conducting spinal systems (the 
neospinothalamic tract, the spinocervical tract, and the post-synaptic neurons in the dorsal column 
system), while the motivational-affective dimension of pain appears to be regulated by the 
brainstem reticular formation and the limbic system, which receive projections from the 
somatosentory pathway.  
The studies which have taken this distinction into account showed that alexithymia might be related 
mostly to the affective, rather than the sensory, dimension of pain and that this association could be 
mediated by psychological distress, especially depression (Honkalamp et al., 2000; Huber et al., 
2009; Lumley et al., 2002; Malt et al., 2002).  
Given this uncertain evidence, the present study aimed at throwing light on the relationship between 
alexithymia and pain in a large sample of FM patients, differentiating between the sensory and 
affective dimensions of pain experience on the basis of Melzack and Casey’s model (1968).  
To achieve this aim, the following specific goals were addressed:  
1. To characterize, for the first time, the clinical profile of alexithymic FM patients by 
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comparing them to non-alexithymic ones on pain (pain experience and pain intensity) and 
psychological distress (anxiety, depression and emotional distress).  
2. To investigate, by means of multiple hierarchical regression analyses, the relationship 
between alexithymia and pain, controlling for psychological distress (anxiety, depression 
and emotional distress).  
 
Methods 
Participants and procedure 
One hundred and fifty-nine female participants with FM (52.5 ± 10.2 years of age) were 
consecutively recruited from the Fibromyalgia Integrated Outpatient Unit (FIOU), a 
multidisciplinary unit based on the collaboration between rheumatologists, psychologists and 
psychiatrists at the San Giovanni Battista University Hospital of Turin. All patients had a main 
diagnosis of fibromyalgia, made by an expert rheumatologist in the field. The exclusion criteria 
were: under 18 years old, low educational level (<5 years) or insufficient knowledge of the Italian 
language, and the presence or history of a neurological or severe psychiatric disorder. 
The usual clinical procedure for FM patients included a first visit to the rheumatologist who 
made/confirmed the diagnosis of FM, and a second visit to a psychologist and a psychiatrist 
together with the rheumatologist to formalize the patient’s care by the FIOU. At a separate session, 
participants filled out psychological questionnaires, after a clinical interview.  
The study was approved by the “Città della Salute e della Scienza”, Hospital of Turin ethics 
committee and was conducted in accordance with the Declaration of Helsinki. All the participants 
gave their written informed consent to participate in the study. 
 
Measures 
Pain evaluation 
The Questionario Italiano sul Dolore (QUID) (De Benedittis et al., 1988), the Italian adaptation of 
the McGill Pain Questionnaire (Melzack and Katz, 1992; Melzack and Katz, 1999), is a self-report 
measure used to assess an individual’s pain experience. Patients chose the adjectives from 16 
subclasses to describe their pain during the previous month. The adjectives from the categories are 
reported as follows: sensory (periodic, pulsing, pounding, penetrating, burning, smarting, tender); 
affective (exhausting, nauseating, suffocating, distressing, hurting); evaluative (annoying, worrying, 
tormenting, nagging, troublesome); mixed (sensory-evaluative; sensory-affective; evaluative).  
For the purposes of the present study, only the scores on the sensory (QUID-S) and the affective 
(QUID-A) dimensions were reported, expressed as a portion of the maximum possible score in each 
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subscale (which ranges from 0 to 1). Several studies have shown the stability and high internal 
consistency of the QUID, as well as the concurrent, predictive and construct validity of its 
component (De Benedittis et al., 1988). 
In addition, as an index of pain intensity, the item “Pain” of the Italian version of the Fibromyalgia 
Impact Questionnaire (FIQ) (Bennett, 2005; Sarzi-Puttini et al., 2003) was used to assess the 
average intensity of pain in the previous week on a scale ranging between 0 and 10. The 
questionnaire evaluates the severity of disability due to FM and it includes 20 items. The overall 
score range from 0 to 100, with the highest score corresponding to the highest level of impairment. 
 
 
Alexithymia 
Alexithymia was assessed using the Italian version of the Toronto Alexithymia Scale (TAS-20) 
(Bressi et al., 1996; Taylor et al., 2003). The subjects were asked to indicate the extent to which 
they agreed or disagreed with each statement on a five-point Likert scale. The results provide a 
TAS-20 total score, and three subscale scores that measure different aspects of alexithymia: 
difficulty identifying feelings (DIF), which measures the inability to distinguish specific emotions 
or between emotions and the bodily sensations of emotional arousal; difficulty describing feelings 
(DDF), which assesses the inability to verbalize one’s emotions to other people; and externally-
oriented thinking (EOT), which evaluates the tendency of individuals to focus their attention 
externally and not on the inner emotional experience (Lumley et al., 2007; Taylor et al., 2003).  
The TAS-20 cut-off scores are as follows: ≤51 no alexithymia, 52–60 borderline alexithymia,  
≥61 alexithymia. This scale has shown good internal consistency and test-retest reliability, as well 
as convergent, discriminant and concurrent validity (Taylor and Bagby, 2004.), and is currently one 
of the most utilized instruments in the study of alexithymia. 
 
Psychological assessment 
The presence of depressive and anxiety symptoms was assessed using the Italian version of the 
Hospital Anxiety and Depression Scale (HADS) (Bjelland et al., 2002; Costantini et al., 1999).  
It consists of 14 items on a 0 to 3 range and is divided into two subscales, one for depression 
(HADS-D) and one for anxiety (HADS-A). Each subscale score ranges from 0 to 21, with a score of 
8 or more suggesting a clinically relevant level of depression/anxiety symptoms (Zigmond and 
Snaith, 1983).  
The level of emotional distress, i.e., the extent of distress that patients experienced over the last week, 
was measured using the Distress Thermometer (DT) (Roth et al., 1998; van Dooren et al., 2009). This 
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is composed of a scale ranging between 0 (No distress) and 10 (Extreme distress). A score equal to 
or greater than 4 indicates clinically relevant distress (Jacobsen et al., 2005).  
Throughout the paper, the term “psychological distress” will be used with reference to depression, 
anxiety and emotional distress scales globally considered.  
 
Statistical analyses 
All the statistical analyses were conducted using IBM SPSS Statistics, version 22.0.  
Normal distribution was assessed using indices of asymmetry and kurtosis. All variables resulted 
normally distributed. First, the total FM sample was divided into alexithymic and non-alexithymic 
groups on the basis of their total TAS-20 scores (total TAS-20 scores ≥61 and ≤51, respectively) 
(Taylor et al., 2003), and independent t-tests or Χ2 tests for categorical data were used to compare 
the two groups.  
Secondly, Pearson correlations were computed to evaluate the possible relationships between 
alexithymia and pain (pain experience and pain intensity), psychological variables (depression, 
anxiety and emotional distress), and demographical/clinical variables (age, educational level and 
duration of illness). Bonferroni correction for multiple testing was applied ( = .05/3). 
Thirdly, hierarchical multiple regression analyses were run to assess whether alexithymia was still a 
significant predictor of the different measures of pain when competing predictors (depression, 
anxiety and emotional distress) were controlled for. Pain measures were used as dependent variables. 
The predictor groups were entered into the regression model according to the following schema: 
potentially confounding variables (age, educational level and duration of illness), alexithymia, and 
competing predictors (depression, anxiety and emotional distress). The enter method was used to 
include the variables of the predictor groups. 
To avoid unnecessary reductions in statistical power, confounding and competing predictors 
variables were included in the regression models only when they were significantly correlated with 
the dependent variables (p <0.017). Collinearity was assessed through the statistical factor of 
tolerance and Variance Inflation Factor (VIF). 
Finally, the PROCESS macro 2.13 for SPSS developed by Andrew F. Hayes (2013) was used to 
test for possible statistical mediation of psychological variables in the relationship between 
alexithymia and pain (Baron and Kenny, 1986; MacKinnon et al., 2007). 
 
Results  
Descriptive data 
The data on the demographic and clinical characteristics of FM sample are presented in Table 1. 
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With regard to the clinical characteristics, FM patients reported 88.9 (± 65.3) months of illness and  
a high rate of pain intensity (FIQ-Pain: 7.1 ± 2.5). 
As far as the psychological assessment was concerned, FM patients showed a high prevalence of 
anxious-depressive symptoms, in line with previous studies (Castelli et al., 2012; Fietta et al., 
2007). In particular, 57.5% of our patients reported a clinically relevant level of anxiety (HADS-A 
≥ 8), while 63.1% reported a clinically relevant level of depression (HADS-D ≥ 8). A high 
prevalence of emotional distress (DT ≥ 4) was also found in 76.9% of the sample.  
Finally, at TAS-20, FM patients reported a higher prevalence of alexithymia compared to the 
general population (Steinweg et al., 2011) (25.8% vs. 6-8%, respectively). 
 
 
Differences between alexithymic and non-alexithymic groups 
The comparisons between the alexithymic and non-alexithymic groups are shown in Table 2.  
The two groups were matched for age (alexithymic group vs. non-alexithymic group, mean ± SD: 
52.2 ± 10.1 vs. 52.3 ± 10.8; t(115) = 0.04, p = NS), educational level (10.1 ± 3.2 vs. 11.0 ± 3.2; 
t(114) = 1.37, p = NS), and duration of illness (106.8 ± 69.6 vs. 80.5 ± 57.6; t(97) = -1.97, p = NS).  
The alexithymic group presented significantly higher scores on QUID-S (p = 0.007), QUID-A (p 
<0.001), FIQ-Pain (p <0.001), HADS-A (p <0.001), HADS-D (p <0.001), and DT (p <0.001), 
compared to the non-alexithymic one. 
For descriptive purposes, comparisons between non-alexithymic vs. borderline and alexithymic vs. 
borderline FM patients were also performed. Borderline group showed significantly higher scores 
on HADS-A (borderline group vs. non-alexithymic group, mean ± SD: 9.8 ± 3.4 vs. 6.9 ± 3.7; 
t(116) = -4.24, p <0.001), HADS-D (10.2 ± 3.8 vs. 7.2 ± 3.8; t(116) = -4.07, p <0.001), and DT (6.3 
± 2.4 vs. 4.7 ± 2.8; t(116) = -3.14, p = 0.002), compared to non-alexithymic one. No significant 
differences emerged on the other measures. As far as the comparisons between alexithymic vs. 
borderline groups were concerned, alexithymic patients presented significantly higher scores on 
HADS-A (alexithymic group vs. borderline group, mean ± SD: 13.2 ± 3.7 vs. 9.8 ± 3.4; t(81) = -
4.37, p <0.001), HADS-D (12.1 ± 3.1 vs. 10.2 ± 3.8; t(81) = -2.53, p = 0.013), DT (7.7 ± 1.6 vs. 6.3 
± 2.4; t(72.4) = -3.16, p = 0.002), FIQ-Pain (8.6 ± 1.8 vs. 6.9 ± 2.6; t(71.7) = -3.23, p = 0.002) and 
QUID-A (0.5 ± 0.2 vs. 0.4 ± 0.2; t(80) = -2.91, p = 0.005), compared to borderline ones. No 
significant differences emerged on the other measures. 
 
 
Correlation Analyses 
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The results of the bivariate correlations are presented in Table 3. Higher scores on alexithymia total 
score and alexithymia DIF and DDF factors were all positively correlated with the affective 
dimension of pain experience (QUID-A), pain intensity (FIQ-Pain), and the three measures of 
psychological distress (depression, anxiety and emotional distress). No correlations were found 
between the EOT factor of the TAS-20 and pain variables, or between other alexithymia scores and 
the sensory dimension of pain experience, age, educational level, and duration of illness.  
 
 
Multiple regressions 
To investigate whether alexithymia was still a significant predictor of pain after controlling for 
competing predictors (depression, anxiety and emotional distress), two hierarchical multiple 
regression analyses were performed. The affective class of QUID was used as a dependent variable 
in the first regression, while the FIQ-Pain was used in the second one. Since the variables of age, 
educational level and duration of illness did not correlate with the dependent variables, they were 
no longer included in the regression analyses.  
With regard to the QUID-A, the alexithymia DIF factor ceased to uniquely predict affective pain 
with the introduction of psychological variables, specifically anxiety, to the model (Table 4).  
The full model of alexithymia, anxiety, depression and emotional distress to predict affective 
dimension of pain experience (Model 2) was statistically significant, R
2
 = .18, F(6, 151) = 5.38, p 
<0.001; adjusted R
2
 = .14. In this case, anxiety (β= 0.27, p = 0.039) was the unique contributor of 
the final model. 
Whereas as far as the FIQ-Pain is concerned, the initial model (Model 1) of alexithymia (DIF and 
DDF factors, and total score) to predict pain intensity was statistically significant, R
2
 = .09, F(3, 
153) = 5.07, p = .002; adjusted R
2
 = .07 (Table 5). However, none of the alexithymia variables 
appeared to significantly contribute to explanation of the FIQ-Pain. The introduction of anxiety, 
depression and emotional distress gave an additional significant contribution to the model  
(Model 2), R
2
 = .23, F(6, 150) = 7.56, p <0.001; adjusted R
2
 = .20. Nevertheless, emotional  
distress (β= 0.28, p = 0.009) was the unique significant predictor in the final model. 
In both regression analyses, the statistical factor of tolerance and VIF showed that there were no 
interfering interactions between the variables. 
Overall, the results of the two hierarchical regressions showed a significant predictor role of the 
DIF factor in explaining the QUID-A, which was no longer present after controlling for 
psychological distress, in particular for anxiety. Whereas none of the alexithymia variables resulted 
significant in explaining the variance of the FIQ-Pain. 
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Mediation analysis 
The results of the hierarchical regression analyses showed a significant contribution of the 
alexithymia DIF factor in explaining the affective dimension of pain experience (QUID-A) which 
was no longer present after controlling for psychological distress, in particular for anxiety. Based on 
these results, we hypothesized a mediation role of anxiety in the relationship between alexithymia 
and affective pain. A mediation analysis was therefore computed in order to verify the effect of 
HADS-A in mediating the relationship between DIF factor of TAS-20 and QUID-A.  
This hypothesis was confirmed, finding a significant indirect effect of DIF on QUID-A through the 
HADS-A, b = 0.01, BCa CI [0.003, 0.01], Z = 3.43, p = <0.001. The effect size of the indirect effect 
was medium 2 = .17, 95% BCa CI [0.094 , 0.272] (it should not be forgotten that small effect size 
2 = .01; medium effect size 2 = .09; large effect size 2 = .25) (Figure 1). 
 
 
Discussion 
The present study aimed to shed light on the relationship between alexithymia and pain in a sample 
of FM patients. To reach this goal, the following specific objectives were addressed. First, we 
evaluated the differences between alexithymic and non-alexithymic subgroups of FM patients on 
pain (pain experience and pain intensity) and psychological distress (anxiety, depression and 
emotional distress). Secondly, we investigated whether alexithymia was a predictor of pain 
measures beyond the effect of psychological distress, and the possible mediation role of the latter in 
the relationship between alexithymia and affective pain. 
To the best of our knowledge, this is the first study comparing alexithymic and non-alexithymc 
subgroups of FM patients. Our results highlighted a significant difference between the two groups 
in all the clinical measures. In particular, alexithymic FM patients showed significantly higher 
levels of pain intensity, pain experience (on both the affective and sensory dimensions), anxiety, 
depression and emotional distress. At the same way, alexithymic FM patients presented 
significantly higher scores in all the clinical measures (except for the QUID-S) when compared to 
borderline ones. Conversely, borderline FM patients showed significantly higher levels of anxiety, 
depression and emotional distress with respect to non-alexithymic ones. 
These data are in line with previous studies which compared alexithymic and non-alexithymic 
samples of chronic pain sufferers, finding that alexithymic individuals reported significantly higher 
scores on pain and psychological distress compared to non-alexithymic ones (Makino et al., 2013; 
Saariaho et al., 2013).  
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A possible explanation for these results could be that individuals who display alexithymic trait at a 
clinical or subclinical level have not only limited abilities to process their emotions, but also great 
difficulty in expressing psychological distress, resulting in a failure to enlist the aid or comfort of 
other people (Taylor et al., 1997). This could lead to increased emotional distress and greater levels 
of depression and anxiety. Moreover, alexithymia may contribute to increasing the disability caused 
by the FM syndrome, making individuals unable to adequately regulate and process their own 
emotions. This could lead FM patients to wrongly interpret their emotional arousal as a sign of 
disease and to seek medical care for symptoms for which there is no clear medical explanation 
(Lumley et al., 1996; Tuzer et al., 2011).  
As far as the second goal of this study is concerned, we analyzed the relationship between 
alexithymia and pain measures, controlling for psychological distress. Regarding the sensory 
component of pain, no correlation was found between the QUID-S and alexithymia. In the same 
way, an initial positive correlation found between FIQ-Pain and alexithymia was not supported by 
the regression analysis. The presence of emotional distress was, in fact, the only predictor that 
mainly explained the variance of FIQ-Pain, demonstrating a non-significant role of alexithymia 
variables or other psychological measures (anxiety and depression) in accounting for pain intensity.  
Whereas with regard to the affective dimension of pain experience, a different pattern of results  
was found. In this case, alexithymia, in particular difficulty in the identifying feelings factor, ceased 
to be a significant predictor of QUID-A, when psychological variables were introduced to the 
model. These data are in line with previous findings which have shown an association exclusively 
between alexithymia and the affective dimension of pain, both in FM (Huber et al., 2009) and in 
other chronic pain conditions (Lumley et al., 2002). Indeed, investigating the relationship between 
alexithymia and the affective/sensory dimensions of ongoing pain in a group of FM patients, Huber 
et al. (2009) found that alexithymia, in particular the DIF factor, was positively related only to the 
affective dimension of ongoing pain and not to the sensory one. However, this association became 
not significant when psychological distress or illness behavior was independently controlled for.  
In the same way, Lumley et al. (2002) analyzed whether alexithymia was related to the affective, 
but not the sensory component of pain, beyond the effect of self-efficacy, catastrophizing, and 
depression, in a sample of patients with chronic myofascial pain. They found that alexithymia was 
positively related only to the affective dimension of pain. Nevertheless, this association remained 
significant only after controlling for self-efficacy and catastrophizing, while depression accounted 
for alexithymia’s relationship with affective pain. 
Although these studies highlighted a selective association between alexithymia and the affective 
dimension of pain, they did not examine in depth the specific effect of psychological distress in the 
 11 
relationship between alexithymia and affective pain. In particular, Huber et al. (2009) performed a 
mediation analysis taking into account the overall general distress and not the specific components 
(i.e. anxiety, depression) as mediator variables, while Lumley et al. (2002), although hypothesizing 
a mediation role of depression in the relationship between alexithymia and affective pain, did not 
perform a mediation analysis to verify it. 
Going further with these studies, we ran a mediation analysis, finding that the relationship between 
alexithymia and affective pain was specifically mediated by anxiety, and not by depression as 
suggested by previous works (Huber et al., 2009; Lumley et al., 2002; Malt et al., 2002). It can be 
speculated that alexithymia interferes with adequate emotion regulation processes, resulting in 
increased negative affects such as anxiety, which in turn may influence the affective dimension of 
pain experience. In addition, it is worth noting that the DIF factor of TAS-20, which accounted for 
alexithymia’s relationship with anxiety and affective pain, deals specifically with emotion 
processing abilities. These results suggest that the affective rather than the cognitive/attentional  
(i.e. EOT subscale) facets of alexithymia may influence the affective dimension of pain experience. 
From a neurological standpoint, the affective component of pain is regulated through a specific 
brain structure, the limbic system, which plays a crucial role also in emotional processing skills.  
In addition, there is evidence in FM patients of structural and functional alterations in brain areas 
(i.e. the amygdala and insula), crucial for both emotional processing abilities and affective pain 
experience (Burgmer et al., 2009; Gracely and Ambrose, 2011). Neuroimaging data could thus be 
useful to support and verify the specific relationship between alexithymia, anxiety and affective 
pain.  
 
Limitations  
The present study has some limitations that should be considered. First, cross-sectional studies do 
not allow certain conclusions about causal direction to be drawn. Longitudinal studies on chronic 
pain patients are needed to better clarify whether alexithymia contributes to increased psychological 
distress and pain, or whether psychological distress impacts negatively on alexithymia and  
other variables.  
Secondly, the use of self-reported instruments might have led to underestimation of, for example, 
the presence of frank alexithymic traits in individuals falling into borderline cut-off scores.  
Paradoxically, explicit self-report measures require the respondents to be aware of their reduced 
ability to identify and describe feelings (Parling et al., 2010). Performance-based instruments or 
structured interviews, less dependent on the patient’s awareness, should be employed in addition to 
traditional self-reported measures. 
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Finally, a control group of patients was not included. Future studies should compare FM sufferers to 
patients with other chronic pain conditions, such as rheumatoid arthritis – a chronic pain pathology 
with a low psychosomatic component – in order to verify the specificity of the results.  
 
Conclusions 
The findings reported in the current study highlight the presence of higher levels of pain symptoms 
and psychological distress in alexithymic FM patients compared to non-alexithymic ones.  
Furthermore, our results show an association between alexithymia, in particular difficulty in 
identifying feelings, and the affective dimension of pain experience, supporting the idea that in 
patients with chronic muscular pain alexithymia is mainly related to the unpleasant component of 
pain, rather than the sensory one. What is more, we found that this relationship is specifically 
mediated by anxiety, suggesting that alexithymia could lead to more affective pain via increases in 
anxiety levels. 
Taken together, these results indicate that adequate assessment of alexithymia and psychological 
distress, in particular of anxiety, may enhance understanding of the affective symptoms of pain in 
FM patients. Consideration of both physical and psychological aspects could allow clinicians to 
plan better-tailored treatments specific for each patient’s needs. 
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Figure 1. Model of alexithymia (DIF factor of TAS-20) as a predictor of affective pain (QUID-A), 
mediated by anxiety (HADS-A). The confidence interval for the indirect effect is a BCa 
bootstrapped CI based on 1,000 samples. 
 
Table 1. Demographic and clinical characteristics of the FM patients (N = 159).  
 Mean (SD) n (%) Range 
Age 52.5 (10.2)  24-74 
Years of education 10.5 (3.3)  5-18 
Duration of illness (months) 88.9 (65.3)  0-288 
Pain     
QUID-S 0.3 (0.1)  0-1 
QUID-A 0.4 (0.2)  0-1 
FIQ-Pain 7.1 (2.5)  0-10 
Psychological Distress    
HADS-A 9.2 (4.5)  0-21 
HADS-D 9.2 (4.2)  0-21 
DT 5.9 (2.8)  0-10 
Alexithymia     
TAS-20 Total 51.6 (13.3)  0-100 
Non-alexithymic  76 (47.8)  
Borderline  42 (26.4)  
Alexithymic   41 (25.8)  
HADS-A 
DIF factor of TAS-20 QUID-A 
b = 0.37, p < .001 
Direct effect, b = 0.003, p = .288 
Indirect effect, b = 0.01, 95% CI [0.003, 0.01] 
b = 0.02, p < .001 
 
DIF factor of TAS-20 QUID-A 
b = 0.01, p < .001 
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TAS-20 DIF 20.1 (7.3)  0-35 
TAS-20 DDF 13.4 (4.8)  0-25 
TAS-20 EOT 18.1 (5.0)  0-40 
 
QUID-S and QUID-A = Sensory and Affective classes of Questionario Italiano sul dolore; FIQ-
Pain = item “Pain” of the Fibromyalgia Impact Questionnaire; HADS-A and HADS-D = Anxiety 
and Depression subscales of the Hospital Anxiety; DT = Distress Thermometer; TAS-20 = Twenty-
item Toronto Alexithymia Scale; TAS-20 DIF = Difficult Identifying Feelings factor of Toronto 
Alexithymia Scale; TAS-20 DDF = Difficulty Describing Feelings factor of Toronto Alexithymia 
Scale; TAS-20 EOT = Externally-Oriented Thinking factor of Toronto Alexithymia Scale. 
 
Table 2. Comparisons between alexithymic and non-alexithymic groups. 
  Alexithymic 
Group 
(N = 41) 
Non- 
alexithymic 
Group 
(N = 76) 
Test (df) p 
QUID-S Mean (SD) 0.4 (0.1) 0.3 (0.1) t(115) = -2.73 .007 
QUID-A Mean (SD) 0.5 (0.2) 0.3 (0.2) t(115) = -3.73 <.001 
FIQ-Pain Mean (SD) 8.6 (1.8) 6.4 (2.3) t(114) = -5.05 <.001 
HADS-A 
Mean (SD) 13.2 (3.7) 6.9 (3.7) t(115) = -8.91 <.001 
n (%) (≥8) 37 (90.2) 26 (34.2) Χ
2
(1) = 33.65 <.001 
HADS-D 
Mean (SD) 12.1 (3.1) 7.2 (3.8) t(96.82) = -7.52 <.001 
n (%) (≥8) 37 (90.2) 32 (42.1) Χ
2
(1) = 25.51 <.001 
DT 
Mean (SD) 7.7 (1.6) 4.7 (2.8) t(114.45) = -7.37 <.001 
n (%) (≥4) 40 (97.6) 48 (63.2) Χ
2
(1) = 16.91 <.001 
 
QUID-S and QUID-A = Sensory and Affective classes of Questionario Italiano sul dolore; FIQ-
Pain = item “Pain” of the Fibromyalgia Impact Questionnaire; HADS-A and HADS-D = Anxiety and 
Depression subscales of the Hospital Anxiety and Depression Scale; DT = Distress Thermometer. 
 
Table 3. Pearson correlations between pain, alexithymia and psychological measures (N = 159). 
 1 2 3 4 5 6 7 
1. QUID-A –       
2. FIQ-Pain .25**       
3. HADS-A  .41** .42**      
4. HADS-D .35** .37** .73**     
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5. DT .35** .43** .70** .64**    
6. TAS-20 Total .26** .29** .60** .52** .46**   
7. TAS-20 DIF .31** .28** .61** .54** .50** .85**  
8. TAS-20 DDF .20* .25** .49** .38** .39** .82** .58** 
 
QUID-S and QUID-A = Sensory and Affective classes of Questionario Italiano sul dolore; FIQ-
Pain = item “Pain” of the Fibromyalgia Impact Questionnaire; HADS-A and HADS-D = Anxiety 
and Depression subscales of the Hospital Anxiety and Depression Scale; DT = Distress Thermometer; 
TAS-20 = Twenty-item Toronto Alexithymia Scale; TAS-20 DIF = Difficult Identifying Feelings 
factor of Toronto Alexithymia Scale; TAS-20 DDF = Difficulty Describing Feelings factor of 
Toronto Alexithymia Scale. 
* p<.017; ** p<.01 
 
Table 4. Hierarchical multiple regression predicting affective dimension of pain experience (QUID-A) 
from alexithymia, anxiety, depression and emotional distress (N = 159). 
Predictor variables B  t R
2
 F R2 F 
Model 1    0.09 5.35** 0.09 5.35** 
TAS-20 Total -0.001 -0.03 -0.15     
TAS-20 DIF 0.009 0.31 1.99*     
TAS-20 DDF 0.002 -0.04 0.28     
Model 2    0.18 5.38** 0.08 4.99** 
TAS-20 Total -0.001 -0.07 -0.31     
TAS-20 DIF 0.004 0.14 0.89     
TAS-20 DDF -0.001 -0.02 -0.14     
HADS-A 0.013 0.27 2.08*     
HADS-D 0.003 0.05 0.45     
DT 0.007 0.09 0.86     
 
TAS-20 = Twenty-item Toronto Alexithymia Scale; TAS-20 DIF = Difficult Identifying Feelings 
factor of Toronto Alexithymia Scale; TAS-20 DDF = Difficulty Describing Feelings factor of 
Toronto Alexithymia Scale; HADS-A and HADS-D = Anxiety and Depression subscales of the 
Hospital Anxiety and Depression Scale; DT = Distress Thermometer.  
* p<.05; ** p<.01 
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Table 5. Hierarchical multiple regression predicting pain intensity (FIQ-Pain) from alexithymia, 
anxiety, depression and emotional distress (N = 159). 
Predictor variables B  t R
2
 F R2 F 
Model 1    0.09 5.07** 0.09 5.07** 
TAS-20 Total 0.007 0.40 0.18     
TAS-20 DIF 0.059 0.18 1.12     
TAS-20 DDF 0.061 0.12 0.84     
Model 2    0.23 7.56** 0.14 9.23** 
TAS-20 Total 0.006 0.32 0.15     
TAS-20 DIF -0.019 -0.06 -0.37     
TAS-20 DDF 0.019 0.04 0.28     
HADS-A 0.102 0.18 1.49     
HADS-D 0.043 0.07 0.67     
DT 0.246 0.28 2.65**     
 
TAS-20 = Twenty-item Toronto Alexithymia Scale; TAS-20 DIF = Difficult Identifying Feelings 
factor of Toronto Alexithymia Scale; TAS-20 DDF = Difficulty Describing Feelings factor of 
Toronto Alexithymia Scale; HADS-A and HADS-D = Anxiety and Depression subscales of the 
Hospital Anxiety and Depression Scale; DT = Distress Thermometer.  
* p<.05; ** p<.01 
 
 
Highlights 
 The relationship between alexithymia and pain was investigated in 159 FM patients. 
 Alexithymic (vs. non-alexithymic) FM patients showed higher pain and distress levels. 
 Alexithymia positively correlated with the affective (not sensory) component of pain. 
 Anxiety significantly mediated the association between alexithymia and affective pain. 
 
